CITIUS PHARMAC Valuation
| 47N Stock | EUR 3.29 0.00 0.00% |
At this time, the firm appears to be overvalued. CITIUS PHARMAC DL shows a prevailing Real Value of €3.16 per share. The current price of the firm is €3.29. Our model approximates the value of CITIUS PHARMAC DL from reviewing the firm fundamentals such as shares outstanding of 146.21 M, and Return On Equity of -0.28 as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that CITIUS PHARMAC's price fluctuation is dangerous at this time. Calculation of the real value of CITIUS PHARMAC DL is based on 3 months time horizon. Increasing CITIUS PHARMAC's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CITIUS stock is determined by what a typical buyer is willing to pay for full or partial control of CITIUS PHARMAC DL. Since CITIUS PHARMAC is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CITIUS Stock. However, CITIUS PHARMAC's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.29 | Real 3.16 | Hype 3.29 | Naive 5.36 |
The real value of CITIUS Stock, also known as its intrinsic value, is the underlying worth of CITIUS PHARMAC DL Company, which is reflected in its stock price. It is based on CITIUS PHARMAC's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CITIUS PHARMAC's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of CITIUS PHARMAC DL helps investors to forecast how CITIUS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CITIUS PHARMAC more accurately as focusing exclusively on CITIUS PHARMAC's fundamentals will not take into account other important factors: CITIUS PHARMAC Total Value Analysis
CITIUS PHARMAC DL is presently estimated to have takeover price of 0 with market capitalization of 186.2 M, debt of 1.06 M, and cash on hands of 115.66 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the CITIUS PHARMAC fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 186.2 M | 1.06 M | 115.66 M |
CITIUS PHARMAC Asset Utilization
One of the ways to look at asset utilization of CITIUS is to check how much profit was generated for every dollar of assets it reports. CITIUS PHARMAC DL shows a negative utilization of assets of -0.16 percent, losing €0.001624 for each euro of assets held by the firm. Ineffective asset utilization signifies that the company is being less capable with each euro of assets it shows. Put another way, asset utilization of CITIUS PHARMAC DL shows how unsuccessful it operates for each euro spent on its assets.CITIUS PHARMAC Ownership Allocation
CITIUS PHARMAC holds a total of 146.21 Million outstanding shares. CITIUS PHARMAC DL shows 8.42 percent of its outstanding shares held by insiders and 11.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.CITIUS PHARMAC Profitability Analysis
Net Loss for the year was (23.66 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates CITIUS PHARMAC's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in CITIUS PHARMAC and how it compares across the competition.
About CITIUS PHARMAC Valuation
The stock valuation mechanism determines CITIUS PHARMAC's current worth on a weekly basis. Our valuation model uses a comparative analysis of CITIUS PHARMAC. We calculate exposure to CITIUS PHARMAC's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CITIUS PHARMAC's related companies.Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products targeting medical needs with a focus on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey. CITIUS PHARMAC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 10 people.
8 Steps to conduct CITIUS PHARMAC's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CITIUS PHARMAC's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CITIUS PHARMAC's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CITIUS PHARMAC's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CITIUS PHARMAC's revenue streams: Identify CITIUS PHARMAC's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CITIUS PHARMAC's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CITIUS PHARMAC's growth potential: Evaluate CITIUS PHARMAC's management, business model, and growth potential.
- Determine CITIUS PHARMAC's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CITIUS PHARMAC's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for CITIUS Stock analysis
When running CITIUS PHARMAC's price analysis, check to measure CITIUS PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CITIUS PHARMAC is operating at the current time. Most of CITIUS PHARMAC's value examination focuses on studying past and present price action to predict the probability of CITIUS PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CITIUS PHARMAC's price. Additionally, you may evaluate how the addition of CITIUS PHARMAC to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Stocks Directory Find actively traded stocks across global markets |